Allumeros BioScience is a preclinical company, creating a new specific and targeted theranostic platform to treat the most difficult of cancer and cardiac conditions
We call this Photonanotherapy™
As the developer of Photonanotherapy™ (PNT) – Our purpose is to give clinicians new tools and therapies for a wide spectrum of difficult to treat conditions – providing the patient with a new alternative that can deliver better outcomes.
Photonanotherapy combines sophisticated photobiology with state of the art targeted nanomedicine, creating a new therapy with broad application across the therapeutic spectrum
PNT is a combination therapy, which can safely image, target and destroy specific diseased tissue
Allumeros will deliver a safe and highly effective, standardized, rapid and economic protocol that addresses multiple difficult to treat conditions across therapeutic segments